Company Profiles

driven by the PitchBook Platform

Metabolon

Description

Developer of metabolics-based diagnostic testing and research services. The company is the developer of a biochemical biomarker discovery and profiling platform with a pipeline of laboratory-developed tests for obesity-related conditions and cancer.

2000

Founded

PRIVATE

Status

51-200

Employees

Series E3

Latest Deal Type

$15M

Latest Deal Amount

$81M

Total Amount Raised

Description

Developer of metabolics-based diagnostic testing and research services. The company is the developer of a biochemical biomarker discovery and profiling platform with a pipeline of laboratory-developed tests for obesity-related conditions and cancer.

Website:

www.metabolon.com

Ownership Status

Privately held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Biotechnology

Other Industries

Laboratory Services (Healthcare)
Discovery Tools (Healthcare)

Primary Office

Post Office Box 110407 Research Triangle Park Durham, NC 27709United States +1 (919) 572-1711
Request a free trial to the PitchBook Platform
You're viewing a free company profile from the PitchBook Platform. To explore Metabolon's full profile, request a free trial.

Metabolon Valuation and Funding

Request access
Deal TypeDateAmountRaised to DatePost-ValStatusStage

Metabolon Cap Table

Stock# of Shares
Authorized
Par ValueDividend Rate (%)Original
Issue Price
LiquidationLiquidation
Pref. Multiple
Conversion
Price
% Owned

Metabolon Investors (16)

Request access
Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
Seat
Contact
Info
Alexandria Real Estate EquitiesReal EstateMinority000 0000000 0000
ATEL VenturesCorporate Venture CapitalMinority000 0000000 0000
Camden PartnersGrowth/ExpansionMinority000 0000000 0000
Crossroads CapitalLender/Debt ProviderMinority000 0000000 0000
Essex WoodlandsGrowth/ExpansionMinority000 0000000 0000
Alexandria Real Estate Equities Real Estate
ATEL Ventures Corporate Venture Capital
Camden Partners Growth/Expansion
Crossroads Capital Lender/Debt Provider
Essex Woodlands Growth/Expansion

Metabolon Executive Team (14)

NameTitleBoard
Seat
Contact
Info
John Ryals Ph.DPresident, Chief Executive Officer & Board Member
Jay TolleyVice President & General Manager, Metabolomics & Biomarker Services
Lisa MillerVice President & General Manager, Precision Medicine
Michael Milburn Ph.DChief Scientific Officer
Robert EllisConsultant
John Ryals Ph.D President, Chief Executive Officer & Board Member
Jay Tolley Vice President & General Manager, Metabolomics & Biomarker Services
Lisa Miller Vice President & General Manager, Precision Medicine
Michael Milburn Ph.D Chief Scientific Officer
Robert Ellis Consultant

Metabolon Board Members (10)

NameRepresentingRoleSinceContact
Info
Christopher Kersey MDCamden PartnersPartner & Managing Member000 0000
David PiersonMetabolonBoard Member000 0000
Guy Fish MDFletcher Spaght VenturesVice President000 0000
Jefferson ClarkThe Aurora FundsCo-Founder & Managing General Partner000 0000
John FletcherFletcher Spaght VenturesFounding Partner000 0000
Christopher Kersey MD Partner & Managing Member Camden Partners
David Pierson Board Member Metabolon
Guy Fish MD Vice President Fletcher Spaght Ventures
Jefferson Clark Co-Founder & Managing General Partner The Aurora Funds
John Fletcher Founding Partner Fletcher Spaght Ventures
Request full access to PitchBook